title: Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival.
abstract: BACKGROUND
  Survival rate for patients presenting muscle invasive bladder cancer is very low, and useful therapeutic target has not been identified yet. In the present study, new COX2 downstream signals involved in urothelial carcinoma cell survival were investigated in vitro and in vivo.
  
  
  METHODS
  COX2 gene was silenced by siRNA transfection. Orthotopic implantation animal model and transurethral instillation of siRNA with atelocollagen was constructed to examine the effects of COX2 knockdown in vivo. Cell cycle was examined by flowcytoketry. Surgical specimens derived from patients with urinary bladder cancer (all were initially diagnosed cases) were used for immunohistochemical analysis of the indicated protein expression in urothelial carcinoma cells.
  
  
  RESULTS
  Treatment with the COX2 inhibitor or knockdown of COX2 reduced expression of casein kinase (CK) 2 α, a phophorylated Akt and urokinase type plasminogen activator (uPA), resulting in p27 induction, cell cycle arrest at G1 phase and cell growth suppression in human urothelial carcinoma cell lines expressing COX2. Silencing of CK2α exhibited the similar effects. Even in UMUC3 cells lacking the COX2 gene, COX2 inhibition also inhibited cell growth through down-regulation of the CK2α-Akt/uPA axis. The mouse orthotropic bladder cancer model demonstrated that the COX2 inhibitor, meloxicam significantly reduced CK2α, phosphorylated Akt and uPA expression, whereas induced p27 by which growth and invasiveness of bladder cancer cells were strongly inhibited. Immunohistochemically, high expression of COX2, CK2α and phosphorylated form of Akt was found in high-grade, invasive carcinomas as well as carcinoma in situ, but not in low-grade and noninvasive phenotypes.
  
  
  CONCLUSIONS
  COX2-dependent and independent activation of CK2α-Akt/uPA signal is mainly involved in urothelial carcinoma cell survival, moreover, not only COX2 but also CK2α could be direct targets of COX2 inhibitors.
authors: Department of Pathology, Nara Medical University School of Medicine, Shijo-cho 840, Kashihara city, Nara, 634-8521, Japan. keijishi@naramed-u.ac.jp
authors: Keiji
authors: K
authors: Shimada
authors: Satoshi
authors: S
authors: Anai
authors: Develasco A
authors: DA
authors: Marco
authors: Kiyohide
authors: K
authors: Fujimoto
authors: Noboru
authors: N
authors: Konishi
references: Cell Mol Life Sci. 2009 Jun;66(11-12):1858-67
references: 19387548
references: J Biol Chem. 2001 May 25;276(21):18563-9
references: 11278747
references: Am J Pathol. 2002 Apr;160(4):1207-14
references: 11943705
references: Histol Histopathol. 2001 Apr;16(2):573-82
references: 11332713
references: Cancer Metastasis Rev. 2009 Dec;28(3-4):305-16
references: 20013032
references: Cancer Res. 2009 Apr 1;69(7):3157-64
references: 19293182
references: Hum Cell. 1988 Mar;1(1):78-83
references: 3154018
references: J Cell Sci. 2002 Oct 15;115(Pt 20):3873-8
references: 12244125
references: Int Urol Nephrol. 2005;37(1):47-53
references: 16132759
references: Cancer Gene Ther. 2002 Aug;9(8):681-6
references: 12136429
references: Cancer Res. 2006 Sep 1;66(17):8389-96
references: 16951148
references: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10832-7
references: 10995457
references: Cancer Lett. 2009 Jan 18;273(2):225-32
references: 18790560
references: Urol Int. 2006;76(1):51-6
references: 16401921
references: Cell. 1995 Nov 3;83(3):493-501
references: 8521479
references: Cancer Metastasis Rev. 2009 Dec;28(3-4):317-26
references: 19997771
references: Carcinogenesis. 2009 Dec;30(12):2047-52
references: 19875696
references: J Pathol. 2005 Aug;206(4):423-32
references: 15906275
references: Carcinogenesis. 2009 Mar;30(3):377-86
references: 19136477
references: Am J Pathol. 2007 Sep;171(3):1003-12
references: 17690186
references: Cell Mol Life Sci. 2009 Oct;66(20):3363-73
references: 19662498
references: Cell Death Differ. 2007 Jan;14(1):158-70
references: 16645640
references: Electrophoresis. 1999 Feb;20(2):391-408
references: 10197447
references: Oncol Rep. 2006 Feb;15(2):471-7
references: 16391871
references: Nat Med. 2004 Aug;10(8):789-99
references: 15286780
references: BJU Int. 2008 Jul;102(2):177-82
references: 18336603
references: Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):63-75
references: 15000150
references: J Urol. 2006 Mar;175(3 Pt 1):1133-7
references: 16469639
references: Int J Cancer. 1993 Sep 30;55(3):498-505
references: 8397167
references: Mol Cell Biochem. 2001 Nov;227(1-2):167-74
references: 11827168